Lacosamide NDC 70518-4689

Product information

Brand name (proprietary)

Lacosamide

Generic name (nonproprietary)

lacosamide

Active ingredients

Lacosamide — 50 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

REMEDYREPACK INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 214695

Marketing start

Jul 3, 2026

Listing expires

Dec 31, 2027

DEA schedule

CV

Other FDA classes

Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)

Identifiers

Product ID 70518-4689_5c266de9-61e6-107b-e063-6394a90af427SPL ID 5c266de9-61e6-107b-e063-6394a90af427

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518468900 followed by a unit qualifier and the quantity Copy

Package 70518-4689-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 214695

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.